Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review
Authors' conclusion
There is some evidence that SES affects use of medications in patients with RA; however, multiple definitions of SES have been utilized, making comparisons between studies difficult.
Study context
- Population
- Studies assessing socioeconomic status (SES) and medication use as an outcome in rheumatoid arthritis (RA) patients; Medline, Embase and PsychInfo from inception until February 202281 of 2,103 studies
- Participants
- 81 participants
- Outcome
- Whether differences in SES variables were associated with differences in medication use
Methodological detailsMost frequent SES measures: education, area-level SES, income, Outcomes mainly DMARD prescription or dispensation, medication adherence, or treatment delays
- Most frequent SES measures: education, area-level SES, income
- Outcomes mainly DMARD prescription or dispensation, medication adherence, or treatment delays
Main finding
As reported in the abstract
Association of SES with medication use
Median number of SES variables measured per study (IQR)
4
3–6
Studies documenting race and/or ethnicity
34
Studies from the US
42%
Further findings
Participant characteristics across included studies
- Mean ± SD age (years)
- 55.9 ± 6.8
- Female
- 75%
Original publication
Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review. Arthritis Care Res (Hoboken). Published 9 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →